Methods of treating, diagnosing or detecting cancer using an EphB3 modulator

Details for Australian Patent Application No. 2006255536 (hide)

Owner Novartis Vaccines and Diagnostics Inc.

Inventors Janatpour, Mary Jo; Zimmerman, Deborah Lee

Agent FB Rice

Pub. Number AU-A-2006255536

PCT Pub. Number WO2006/132907

Priority 60/687,429 03.06.05 US

Filing date 2 June 2006

Wipo publication date 14 December 2006

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/132907 Priority application(s): WO2006/132907

12 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006255550-User interface for web analytics tools and methods for automatic generation of calendar notes, targets and alerts

2006255531-A gaming system